SIMCERE PHARMAC. GRP LTD (S2P) — Cash Flow Quality Index
SIMCERE PHARMAC. GRP LTD (S2P) has a Cash Flow Quality Index of 1.50x as of December 2025. Operating cash flow of €2.01 Billion exceeds net income of €1.34 Billion, indicating high earnings quality where cash backs reported profits. Also explore S2P asset base for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
SIMCERE PHARMAC. GRP LTD Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for SIMCERE PHARMAC. GRP LTD across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check SIMCERE PHARMAC. GRP LTD tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for SIMCERE PHARMAC. GRP LTD (2021–2025)
Year-by-year earnings quality comparison for SIMCERE PHARMAC. GRP LTD. For live market cap and the full company financial profile, see market cap of SIMCERE PHARMAC. GRP LTD.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.50x | €2.01 Billion | €1.34 Billion | ▼ -89.1% |
| 2024 | 13.76x | €1.39 Billion | €101.13 Million | ▲ +804.2% |
| 2023 | 1.52x | €151.05 Million | €99.28 Million | ▼ -84.7% |
| 2022 | 9.97x | €1.35 Billion | €135.79 Million | ▲ +1268.6% |
| 2021 | -0.85x | €-201.97 Million | €236.69 Million | — |